Multiple Sclerosis Headlines

Online Keyboard Tapping Assessment Accurately Evaluates MS Disease Severity

Online Keyboard Tapping Assessment Accurately Evaluates MS Disease Severity

The BRAIN test is limited by its ability to only assess upper limb function.

Oral, IV Methylprednisolone Show Similar Benefits for Multiple Sclerosis Relapse

Oral, IV Methylprednisolone Show Similar Benefits for Multiple Sclerosis Relapse

While both intravenous and oral administrations of methylprednisolone showed similar efficacy, the investigators noted that oral administration may be more tolerable and cost-effective.

Fingolimod Wins Breakthrough Designation for Pediatric Multiple Sclerosis

Fingolimod Wins Breakthrough Designation for Pediatric Multiple Sclerosis

The FDA has granted Breakthrough Therapy designation to Fingolimod for treating children with relapsing multiple sclerosis.

Diet Linked to Multiple Sclerosis Disability, Disease Severity

Diet Linked to Multiple Sclerosis Disability, Disease Severity

Diet quality is associated with disability and symptom severity in multiple sclerosis patients.

Increased Epilepsy Risk Identified in Multiple Sclerosis

Increased Epilepsy Risk Identified in Multiple Sclerosis

Investigators believe this is the largest study on the association between multiple sclerosis and epilepsy.

Serum Neurofilament Light Levels Help Indicate Multiple Sclerosis Response to Therapy

Serum Neurofilament Light Levels Help Indicate Multiple Sclerosis Response to Therapy

While a useful biomarker, sampling of serum NfL requires multiple lumbar spine punctures.

Percutaneous Transluminal Angioplasty Shown to Be Ineffective in MS

Percutaneous Transluminal Angioplasty Shown to Be Ineffective in MS

For patients with MS and CCSVI, precutaneous transluminal angioplasty seems to be safe but not effective.

Visualizing Peripheral Nerve Involvement in MS With Magnetic Resonance Neurography

Visualizing Peripheral Nerve Involvement in MS With Magnetic Resonance Neurography

Peripheral nerve involvement can be visualized and quantified by high-resolution MRN in MS patients.

Risk for Multiple Sclerosis Associated With Epstein-Barr, Cytomegalovirus Infection

Risk for Multiple Sclerosis Associated With Epstein-Barr, Cytomegalovirus Infection

Investigators strived to determine the association between multiple sclerosis and Epstein-Barr virus or cytomegalovirus infection in certain racial groups.

Drug May Slow Conversion to Definite MS From Clinically Isolated Syndrome

Drug May Slow Conversion to Definite MS From Clinically Isolated Syndrome

Aubagio may cause delays in conversion to clinical definite MS by slowing the loss of cortical grey matter.

Switch to Alemtuzumab Reduces MS Disease Activity

Switch to Alemtuzumab Reduces MS Disease Activity

Patients experienced reduced disease activity when switched to alemtuzumab.

Dimethyl Fumarate as Exit Strategy From Natalizumab Treatment in Multiple Sclerosis

Dimethyl Fumarate as Exit Strategy From Natalizumab Treatment in Multiple Sclerosis

Patients with relapsing-remitting multiple sclerosis with high titers of JCV antibodies and who were being treated with natalizumab for more than 2 years were enrolled in the study.

Disability Progression Slowed in Relapsing MS With Ocrelizumab Treatment

Disability Progression Slowed in Relapsing MS With Ocrelizumab Treatment

Data show superiority of OCREVUS compared to Rebif in reducing disability progression independent of relapse activity in people with RMS.

Novel Multiple Sclerosis Drug Shows Promise

Novel Multiple Sclerosis Drug Shows Promise

Celgene announced new Phase 3 data evaluating the safety and efficacy of ozanimod vs Avonex for RMS.

Fingolimod Promising for Pediatric Relapsing Multiple Sclerosis

Fingolimod Promising for Pediatric Relapsing Multiple Sclerosis

There are no FDA-approved MS therapies for the pediatric population.

Comorbidities in Multiple Sclerosis Associated With Diagnostic Delays, Mortality Risk

Comorbidities in Multiple Sclerosis Associated With Diagnostic Delays, Mortality Risk

As early treatment of multiple sclerosis is crucial, it is important to identify the factors that may delay diagnosis.

Comorbidities May Increase Relapse Risk in Multiple Sclerosis

Comorbidities May Increase Relapse Risk in Multiple Sclerosis

An emerging line of inquiry suggests a potential association between comorbidities and MS relapses, but studies have been limited.

OSA Screening Advised for Fatigued Patients With MS

OSA Screening Advised for Fatigued Patients With MS

Patients with multiple sclerosis who experience severe fatigue should be screened for obstructive sleep apnea.

Multiple Sclerosis Lesion Location Linked to Hyperalgesia, Hypoalgesia

Multiple Sclerosis Lesion Location Linked to Hyperalgesia, Hypoalgesia

In patients with multiple sclerosis, lesions in the right dorsolateral prefrontal cortex may be associated with hypoalgesia, and lesions in the posterior periventricular area, with hyperalgesia.

Earlier Onset of Multiple Sclerosis Linked to Cesarean Delivery, Artificial Lactation

Earlier Onset of Multiple Sclerosis Linked to Cesarean Delivery, Artificial Lactation

Researchers believe that environmental factors may impact disease severity characteristics in genetically susceptible populations.

Sign Up for Free e-newsletters

CME Focus